X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1341) 1341
Publication (96) 96
Book Review (21) 21
Book Chapter (8) 8
Dissertation (4) 4
Book / eBook (3) 3
Conference Proceeding (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
isolated limb perfusion (807) 807
humans (772) 772
oncology (573) 573
index medicus (459) 459
male (455) 455
animals (434) 434
female (384) 384
melphalan (354) 354
surgery (347) 347
melanoma (335) 335
middle aged (280) 280
tumor-necrosis-factor (280) 280
aged (273) 273
adult (229) 229
cancer (223) 223
chemotherapy (215) 215
melanoma - drug therapy (189) 189
chemotherapy, cancer, regional perfusion (183) 183
melphalan - administration & dosage (179) 179
interferon-gamma (178) 178
sarcoma (177) 177
tnf-alpha (172) 172
chemotherapy, cancer, regional perfusion - methods (152) 152
perfusion (152) 152
rats (150) 150
factor-alpha (148) 148
malignant-melanoma (148) 148
treatment outcome (141) 141
extremities (138) 138
tumor necrosis factor-alpha - administration & dosage (136) 136
aged, 80 and over (131) 131
medicine & public health (126) 126
combined modality therapy (117) 117
skin neoplasms - drug therapy (117) 117
melanoma - pathology (113) 113
pharmacology & pharmacy (113) 113
skin neoplasms - pathology (110) 110
necrosis-factor-alpha (106) 106
prognosis (102) 102
antineoplastic agents - therapeutic use (98) 98
mice (98) 98
antineoplastic agents, alkylating - administration & dosage (96) 96
care and treatment (96) 96
hyperthermia, induced (96) 96
sarcoma - drug therapy (96) 96
melanoma - therapy (92) 92
tumor necrosis factor-alpha - therapeutic use (86) 86
antineoplastic agents - administration & dosage (85) 85
radiology, nuclear medicine & medical imaging (84) 84
soft-tissue sarcoma (84) 84
tumor necrosis factor (83) 83
isolated limb infusion (82) 82
melphalan - therapeutic use (76) 76
surgical oncology (76) 76
antineoplastic combined chemotherapy protocols - therapeutic use (75) 75
neoplasm staging (75) 75
soft tissue sarcoma (75) 75
in vitro techniques (72) 72
isolated hepatic perfusion (72) 72
melanoma - secondary (72) 72
toxicity (72) 72
survival rate (71) 71
combination (70) 70
metastasis (67) 67
soft-tissue sarcomas (67) 67
therapy (66) 66
dose-response relationship, drug (65) 65
radiotherapy (65) 65
physiology (63) 63
research (63) 63
skin neoplasms - therapy (62) 62
adolescent (61) 61
medicine, research & experimental (61) 61
analysis (60) 60
hyperthermia (60) 60
neoplasms - drug therapy (60) 60
retrospective studies (60) 60
disease models, animal (59) 59
metastases (59) 59
sarcoma - pathology (59) 59
tumors (58) 58
time factors (57) 57
extremity (56) 56
survival (56) 56
follow-up studies (55) 55
immunotherapy (55) 55
regional chemotherapy (55) 55
phase-i (54) 54
tumor necrosis factor-alpha - pharmacology (54) 54
antineoplastic agents, alkylating - therapeutic use (53) 53
biochemistry & molecular biology (53) 53
melanoma - surgery (53) 53
apoptosis (52) 52
health aspects (52) 52
prognostic-factors (52) 52
antineoplastic combined chemotherapy protocols - administration & dosage (51) 51
sarcoma - therapy (51) 51
cardiac & cardiovascular systems (50) 50
tnf (50) 50
cell biology (49) 49
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1278) 1278
German (49) 49
French (23) 23
Spanish (6) 6
Japanese (5) 5
Italian (2) 2
Portuguese (1) 1
Russian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Zdravniški Vestnik, ISSN 1318-0347, 02/2016, Volume 85, Issue 1
Isolated limb perfusion is a surgical procedure that can be used to treat an advanced malignant melanoma and soft tissue sarcomas, it is also effective in... 
isolated limb perfusion, melanoma, soft tissue sarcomas, in-transit metastases, cytostatic agents, hyperthermia
Journal Article
European Journal of Cancer, ISSN 0959-8049, 09/2018, Volume 100, pp. 46 - 54
Isolated limb perfusion (ILP) is a well-established treatment for patients with advanced extremity malignancies unsuitable for limb-conserving surgery.... 
Geriatric oncology | Soft-tissue sarcoma | Melanoma | Isolated limb perfusion | SURVIVAL | MULTICENTER | STAGE-III | FACTOR-ALPHA | TUMOR-NECROSIS-FACTOR | ONCOLOGY | ADVANCED MELANOMA | QUALITY-OF-LIFE | MELPHALAN | IPILIMUMAB | Skin | Sarcoma | Health aspects | Mortality | Cancer | Index Medicus
Journal Article
Journal Article
International Journal of Hyperthermia, ISSN 0265-6736, 08/2017, Volume 33, Issue 6, pp. 679 - 683
Journal Article
JOURNAL OF NUCLEAR MEDICINE, ISSN 0161-5505, 11/2019, Volume 60, Issue 11, pp. 1537 - 1542
Our purpose was to assess the diagnostic potential of simultaneously acquired F-18-FDG PET and MRI data sets for therapy response assessment of isolated limb... 
CRITERIA | TOMOGRAPHY | REGRESSION | RECIST | soft-tissue sarcoma | isolated limb perfusion | TUMOR-NECROSIS-FACTOR | PET/MRI | NEOADJUVANT CHEMOTHERAPY | OSTEOSARCOMA | therapy response assessment | TNF-ALPHA | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PET
Journal Article
Journal Article
CANCER, ISSN 0008-543X, 09/2016, Volume 122, Issue 17, pp. 2624 - 2632
The management of locally advanced extremity soft tissue sarcoma of the limbs is challenging, particularly for recurrent tumors and those adjacent to... 
ADJUVANT CHEMOTHERAPY | limb salvage | extremity soft tissue sarcoma | CLINICAL-TRIAL | multimodal therapy | RANDOMIZED-TRIAL | PHASE-II | FACTOR-ALPHA | REGIONAL PERFUSION | isolated limb perfusion | NEOADJUVANT CHEMOTHERAPY | HIGH-GRADE | ONCOLOGY | HIGH-RISK | TNF-ALPHA | recombinant human tumor necrosis factor (rhTNF)
Journal Article
European Journal of Cancer, ISSN 0959-8049, 11/2017, Volume 85, pp. 114 - 121
Angiosarcomas are rare and aggressive soft-tissue sarcomas. The only potential curative treatment is complete surgical excision. This study reports the outcome... 
Cutaneous angiosarcoma of the extremity | Sarcoma | Limb salvage technique | Locally advanced angiosarcoma | Angiosarcoma | ILP | Isolated limb perfusion | RESECTION | IN-TRANSIT METASTASES | CUTANEOUS ANGIOSARCOMA | FACTOR-ALPHA | PACLITAXEL | TUMOR-NECROSIS-FACTOR | MELANOMA | ONCOLOGY | SINGLE-INSTITUTION EXPERIENCE | MELPHALAN | SOFT-TISSUE SARCOMA | Chemotherapy, Cancer, Regional Perfusion - adverse effects | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Young Adult | Netherlands | Melphalan - adverse effects | Time Factors | Amputation | Aged, 80 and over | Adult | Female | Retrospective Studies | Chemotherapy, Cancer, Regional Perfusion - methods | Hemangiosarcoma - secondary | Databases, Factual | Soft Tissue Neoplasms - therapy | Hemangiosarcoma - therapy | Limb Salvage | Soft Tissue Neoplasms - mortality | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Extremities - pathology | Treatment Outcome | Chemotherapy, Cancer, Regional Perfusion - mortality | Hemangiosarcoma - mortality | Regional Blood Flow | Disease Progression | Hemangiosarcoma - blood supply | Disease-Free Survival | Retreatment | Melphalan - administration & dosage | Soft Tissue Neoplasms - blood supply | Extremities - blood supply | Tumor Necrosis Factor-alpha - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Soft Tissue Neoplasms - pathology | London | Tumor Necrosis Factor-alpha - administration & dosage | Aged | Therapeutics | Homeopathy | Materia medica and therapeutics | Index Medicus
Journal Article
European Journal of Oncology Nursing, ISSN 1462-3889, 12/2019, Volume 43, p. 101672
In recent years, the incidence of malignant melanoma has rapidly increased worldwide. Among patients with recurrences, approximately 5% develop in-transit... 
Malignant melanoma | Experiences | Qualitative | Patients | Cancer | Isolated limb perfusion | Content analysis
Journal Article
International Journal of Hyperthermia, ISSN 0265-6736, 10/2017, Volume 33, Issue 7, pp. 862 - 866
Journal Article